Literature DB >> 15618241

National survey of palliative care in end-stage renal disease in the UK.

Smita Gunda1, Mark Thomas, Steve Smith.   

Abstract

BACKGROUND: Palliative care for patients with end-stage renal disease (ESRD) is a neglected aspect of nephrology. We carried out this survey to establish the current pattern of provision of palliative care for ESRD in the UK.
METHODS: An anonymous but numbered questionnaire concerning local palliative care provision was sent to clinical directors of all 69 UK renal units.
RESULTS: All the questionnaires were returned. Only 27 (39%) units employ nursing or Professions Allied to Medicine (PAM) staff with palliative care for ESRD patients as a specified part of their role. In 19 of these units, staff spend <4 h per week concerned with palliative care and only five units have staff working for >12 h a week in this role. Fifty-five (80%) units do not have a written protocol for palliative care. Anaemic ESRD patients with an expected survival of >3 months receive blood transfusion in 59 (86%) units, intravenous iron in 61 (88%) units and erythropoietin in 63 (91%) units. Only 37 (54%) units kept a record of patients seen by the unit staff but deemed not suitable for dialysis.
CONCLUSION: There is a significant variation in provision of palliative care services across the UK. In some areas, access to palliative care is restricted to patients with malignant disease, and ESRD patients are excluded.

Entities:  

Mesh:

Year:  2004        PMID: 15618241     DOI: 10.1093/ndt/gfh619

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  International Study of Health Care Organization and Financing of renal services in England and Wales.

Authors:  Tricia Nicholson; Paul Roderick
Journal:  Int J Health Care Finance Econ       Date:  2007-12

2.  Conservative care for ESRD in the United Kingdom: a national survey.

Authors:  Ikumi Okamoto; Sarah Tonkin-Crine; Hugh Rayner; Fliss E M Murtagh; Ken Farrington; Fergus Caskey; Charles Tomson; Fiona Loud; Roger Greenwood; Donal J O'Donoghue; Paul Roderick
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-11       Impact factor: 8.237

Review 3.  Palliative care in non-malignant diseases.

Authors:  D C Traue; J R Ross
Journal:  J R Soc Med       Date:  2005-11       Impact factor: 18.000

4.  Hospice care access inequalities: a systematic review and narrative synthesis.

Authors:  Jake Tobin; Alice Rogers; Isaac Winterburn; Sebastian Tullie; Asanish Kalyanasundaram; Isla Kuhn; Stephen Barclay
Journal:  BMJ Support Palliat Care       Date:  2021-02-19       Impact factor: 4.633

5.  Exploring access to end of life care for ethnic minorities with end stage kidney disease through recruitment in action research.

Authors:  Emma Wilkinson; Gurch Randhawa; Edwina Brown; Maria Da Silva Gane; John Stoves; Graham Warwick; Tahira Akhtar; Regina Magee; Sue Sharman; Ken Farrington
Journal:  BMC Palliat Care       Date:  2016-07-11       Impact factor: 3.234

6.  Health-related quality of life, palliative care needs and 12-month survival among patients with end stage renal disease in Uganda: protocol for a mixed methods longitudinal study.

Authors:  Peace Bagasha; Mhoira Leng; Elly Katabira; Mila Petrova
Journal:  BMC Nephrol       Date:  2020-12-07       Impact factor: 2.388

7.  Shared decision-making and planning end-of-life care for patients with end-stage kidney disease: a protocol for developing and testing a complex intervention.

Authors:  Louise Engelbrecht Buur; Jeanette Finderup; Henning Søndergaard; Michell Kannegaard; Jens Kristian Madsen; Hilary Louise Bekker
Journal:  Pilot Feasibility Stud       Date:  2022-10-04

8.  Perceptions of Illness Severity, Treatment Goals, and Life Expectancy: The ePISTLE Study.

Authors:  Hannah K S Beckwith; Anamika Adwaney; Maura Appelbe; Helen T Gaffney; Peter Hill; Dihlabelo Moabi; Virginia L Prout; Emma Salisbury; Phil Webster; James A P Tomlinson; Edwina A Brown
Journal:  Kidney Int Rep       Date:  2021-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.